Skip to main navigation Skip to search Skip to main content

An Open Label Randomized Parallel Group Pharmacokinetics Trial of Tipranavir TPV RTV Alone or in Combination With RTV Boosted Saquinavir SQV Amprenavir APV or Lopinavir Plus an Optimised Background Regimen in Multaple Antiretroviral

Grants and Contracts Details

StatusFinished
Effective start/end date3/1/03 → 6/30/07

Funding

  • Boehringer-Ingelheim: $7,700.00